phrykt

BeOne Medicines (ONC) net income: $287M

BeOne Medicines reported a net income of $287M for the year ended Dec 31, 2025.

From BeOne Medicines's filings with the SEC · Read the filing · ONC stock page

BeOne Medicines net income by year

−$1.5B2021−$2B2022−$882M2023−$645M2024$287M2025

#820 of 3,748 US companies by net income · See the full ranking

Year endedNet incomeChange
Dec 31, 2025$287M–
Dec 31, 2024−$645M–
Dec 31, 2023−$882M–
Dec 31, 2022−$2B–
Dec 31, 2021−$1.5B–

Net income of similar companies

Companies in the same industry as BeOne Medicines, by SEC industry code, with the closest net income. Each name opens the same page for that company.

CompanyNet income, latest yearYear ended
Acadia Pharmaceuticals$391MDec 31, 2025
Rigel Pharmaceuticals$367MDec 31, 2025
Biomarin Pharmaceutical$349MDec 31, 2025
Alnylam Pharmaceuticals$314MDec 31, 2025
Aurinia Pharmaceuticals$287MDec 31, 2025
BeOne Medicines$287MDec 31, 2025
Alkermes$242MDec 31, 2025

Questions and answers

What is BeOne Medicines's net income?

BeOne Medicines reported a net income of $287M for the year ended Dec 31, 2025.

Numbers as reported in BeOne Medicines's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology